Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v8-FR
Language English French
Date Updated 2024-02-13 2024-02-12
Drug Identification Number 02213826 02213826
Brand name REVIA REVIA
Common or Proper name REVIA 50MG TAB REVIA 50MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NALTREXONE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 50 50
ATC code N07BB N07BB
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-10 2024-01-10
Estimated end date 2024-02-10 2024-02-10
Actual end date 2024-02-12 2024-02-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments